Skip to main content
Fig. 6 | Journal for ImmunoTherapy of Cancer

Fig. 6

From: PD-L1 expression is a predictive biomarker for CIK cell-based immunotherapy in postoperative patients with breast cancer

Fig. 6

Kaplan-Meier curves of breast cancer patients based on postoperative treatment. a OS and RFS curves of patients in CIK treatment group. Significantly improved prognosis was observed in patients with PD-L1-positive expression. b OS and RFS curves of patients in the control group. Patients with PD-L1-negative expression had better prognosis than patients with PD-L1-positive expression

Back to article page